EmpowerPharm Awaits Phase II Clinical Trial On Ground Breaking Cannabidiol Treatment To Manage Social Anxiety Disorder

Burlington, ON March 11, 2024– EmpowerPharm Inc. is delighted to announce that the final participant has completed their treatment in the Phase II clinical trial assessing the efficacy of pharmaceutical-grade Cannabidiol (CBD) for Social...
Source: Drugs.com - Clinical Trials - Category: Pharmaceuticals Source Type: clinical trials